MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-12-2025
CorMedix DPO Ratio 2011-2025 | CRMD
Annual DPO Ratio CorMedix
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 216 K | 4.09 K | 2.01 K | 1 K | 2.38 K | 5.74 K | 1.64 K | 1.96 K | 731 | 1.7 K | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 216 K | 731 | 23.7 K |
Quarterly DPO Ratio CorMedix
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 158 | 190 | 104 | - | 337 | - | - | - | - | - | - | - | 132 K | 582 K | 118 K | - | 3.72 K | 7.73 K | 1.96 K | - | 1.29 K | 5.37 K | 2.02 K | - | 1.18 K | 4.42 K | 726 | - | 756 | 7.02 K | 7.02 K | - | 2.48 K | 9.14 K | 1.68 K | -1.77 M | 3.42 K | 802 | 3.05 K | -951 K | -4.46 M | -1.53 M | -6.99 M | - | -2.22 K | -1.5 K | -1.03 K | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 582 K | -6.99 M | -448 K |
DPO Ratio of other stocks in the Biotechnology industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aclaris Therapeutics
ACRS
|
887 | $ 3.04 | 0.33 % | $ 235 M |  USA |
 |
Aptevo Therapeutics
APVO
|
239 | $ 0.55 | -10.18 % | $ 152 K | USA |
 |
Midatech Pharma plc
MTP
|
162 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
78.2 | - | - | $ 40.3 B | USA |
 |
Aptorum Group Limited
APM
|
405 | $ 1.15 | 1.19 % | $ 6.27 M |  China |
 |
AIkido Pharma
AIKI
|
32.8 K | - | 1.93 % | $ 17.4 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
2.85 K | - | -11.43 % | $ 502 K | USA |
 |
BioDelivery Sciences International
BDSI
|
96.3 | - | -4.8 % | $ 255 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
115 | - | - | - |  Russia |
 |
Acasti Pharma
ACST
|
4.39 K | - | 4.01 % | $ 150 M |  Canada |
 |
Berkeley Lights
BLI
|
135 | - | -7.31 % | $ 87 M | USA |
 |
Catalyst Biosciences
CBIO
|
18.8 | $ 12.24 | -0.93 % | $ 806 M | USA |
 |
Albireo Pharma
ALBO
|
1.59 K | - | -0.23 % | $ 916 M | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
28.5 | $ 27.02 | -0.37 % | $ 1.31 B | USA |
 |
BeiGene, Ltd.
BGNE
|
915 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Certara
CERT
|
10.2 | $ 8.83 | -0.67 % | $ 1.42 B | USA |
 |
Anika Therapeutics
ANIK
|
54.4 | $ 9.57 | 0.21 % | $ 140 M | USA |
 |
bluebird bio
BLUE
|
182 | - | - | $ 546 M | USA |
 |
Arena Pharmaceuticals
ARNA
|
142 | - | -6.81 % | $ 3.04 B | USA |
 |
Cellectis S.A.
CLLS
|
975 | $ 4.91 | 3.37 % | $ 116 M |  France |
 |
Axon Enterprise
AXON
|
29.9 | $ 580.12 | -0.64 % | $ 43.9 B | USA |
 |
Ayala Pharmaceuticals
AYLA
|
2.21 K | - | - | $ 7.46 M |  Israel |
 |
Aytu BioScience
AYTU
|
186 | $ 2.47 | 0.82 % | $ 15.5 M | USA |
 |
ChromaDex Corporation
CDXC
|
90.1 | - | -0.88 % | $ 598 M | USA |
 |
AstraZeneca PLC
AZN
|
265 | $ 92.71 | -0.2 % | $ 96.9 B | Britain |
 |
Acorda Therapeutics
ACOR
|
277 | - | -24.86 % | $ 820 K | USA |
 |
Brickell Biotech
BBI
|
105 | - | -5.38 % | $ 6.06 M | USA |
 |
Corcept Therapeutics Incorporated
CORT
|
550 | $ 81.86 | -0.96 % | $ 8.45 B | USA |